Verily Life Sciences
Verily Life Sciences Raises $1B in Series D
Quick Facts
Verily Life Sciences Raises $1B in Series D
Verily Life Sciences has successfully raised $1B in a Series D at a $6B valuation led by Temasek, Silver Lake, Ontario Teachers.
Company Overview
Verily Life Sciences is a HealthTech company headquartered in South San Francisco, CA, founded in 2015 with 1500+ employees.
Precision health and life sciences research
Fundraising Details
- Amount Raised: $1B
- Round Type: Series D
- Valuation: $6B
- Date: 2022-01-12
- Investors: Temasek, Silver Lake, Ontario Teachers
About Verily Life Sciences
Precision health and life sciences research The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: South San Francisco, CA
- Founded: 2015
- Team Size: 1500+
- Industry: HealthTech
What This Means
This funding round demonstrates strong investor confidence in Verily Life Sciences's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Verily Life Sciences's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $6B valuation marks an important milestone for Verily Life Sciences, positioning the company among notable players in the HealthTech industry.
Looking Ahead
With this new capital, Verily Life Sciences is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2022-01-12. For more information about Verily Life Sciences, visit their headquarters at South San Francisco, CA.
About the Author
Related Company Reports
Harvey AI Raises $160 million in Series F
Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.
7AI Raises $130 million in Series A
7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.
TRIANA Biomedicines Raises $120 million in Series B
TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.